| scholarly article | Q13442814 |
| P50 | author | James A. Blumenthal | Q88513900 |
| Barbara Phillips-Bute | Q115549094 | ||
| P2093 | author name string | Daniel T Laskowitz | |
| Donald D Glower | |||
| Hilary P Grocott | |||
| Joseph P Mathew | |||
| Mark F Newman | |||
| G Burkhard Mackensen | |||
| Neurologic Outcome Research Group (NORG) of the Duke Heart Center | |||
| P2860 | cites work | Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery | Q28199892 |
| Preliminary report of the effects of complement suppression with pexelizumab on neurocognitive decline after coronary artery bypass graft surgery | Q28279137 | ||
| Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
| Cognitive change 5 years after coronary artery bypass surgery | Q34279265 | ||
| Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial | Q34630022 | ||
| Lidocaine in the treatment of decompression illness: a review of the literature. | Q34687513 | ||
| Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery | Q36493915 | ||
| Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages | Q36634164 | ||
| Clinical Pharmacokinetics of Lignocaine | Q39725309 | ||
| Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables | Q41718792 | ||
| Effect of the duration of infusion on the disposition of lidocaine in dogs | Q42596848 | ||
| Cognition 6 years after surgical or medical therapy for coronary artery disease | Q43485658 | ||
| Effects of ion channel blockade on the distribution of Na, K, Ca and other elements in oxygen-glucose deprived CA1 hippocampal neurons | Q43574467 | ||
| Prospective randomized trial of normothermic versus hypothermic cardiopulmonary bypass on cognitive function after coronary artery bypass graft surgery | Q43783508 | ||
| Effect of experimental diabetes on pharmacokinetic parameters of lidocaine and MEGX in rats | Q44634227 | ||
| Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats | Q44852860 | ||
| Lidocaine impairs vasodilation mediated by adenosine triphosphate-sensitive K+ channels but not by inward rectifier K+ channels in rat cerebral microvessels | Q45034045 | ||
| Lidocaine delays cortical ischemic depolarization: relationship to electrophysiologic recovery and neuropathology | Q48150111 | ||
| Cerebral protection by lidocaine during cardiac operations | Q48216002 | ||
| Cytosolic Ca2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+-dependent Ca2+ release from mitochondria. | Q48230980 | ||
| An evaluation of the effect of lidocaine in experimental focal cerebral ischemia | Q48302778 | ||
| Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients | Q48357237 | ||
| Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism | Q48425244 | ||
| The effects of lidocaine on canine cerebral metabolism and circulation related to the electroencephalogram. | Q48558841 | ||
| Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly | Q48561058 | ||
| Lidocaine metabolism in isolated perfused liver from streptozotocin-induced diabetic rats | Q48677642 | ||
| Neurocognitive deficit following coronary artery bypass grafting: a prospective study of surgical patients and nonsurgical controls | Q48864614 | ||
| Brain microemboli during cardiac surgery or aortography | Q48886524 | ||
| The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery | Q49023484 | ||
| Cerebral arterial gas embolism by helium: an unusual case successfully treated with hyperbaric oxygen and lidocaine. | Q51416030 | ||
| Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. | Q51535992 | ||
| Lidocaine reduces the hypoxia-induced release of an excitatory amino acid analog from rat striatal slices in superfusion. | Q51595098 | ||
| Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. | Q51604307 | ||
| Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials. | Q51619927 | ||
| Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: a microdialysis study in Mongolian gerbils. | Q51624967 | ||
| The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects. | Q51792100 | ||
| Reduction of experimental intracranial hypertension by lidocaine. | Q51792269 | ||
| Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. | Q51831269 | ||
| Protective effect of lidocaine in acute cerebral ischemia induced by air embolism. | Q51848363 | ||
| Inhibition of Cerebral Oxygen and Glucose Consumption in the Dog by Hypothermia, Pentobarbital, and Lidocaine | Q51865990 | ||
| Pharmacokinetic Principles of Lidocaine Dosing in Relation to Disease State | Q51868222 | ||
| Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. | Q51875061 | ||
| Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. | Q52707629 | ||
| Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite | Q52717137 | ||
| The convulsant potency of lidocaine and its N-dealkylated metabolites | Q52729244 | ||
| Increased myogenic tone and diminished responsiveness to ATP-sensitive K+ channel openers in cerebral arteries from diabetic rats | Q73944477 | ||
| Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery | Q80324479 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiac surgery | Q235007 |
| placebo | Q269829 | ||
| lidocaine | Q216935 | ||
| P304 | page(s) | 880-887 | |
| P577 | publication date | 2009-01-22 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery | |
| P478 | volume | 40 |
| Q42291875 | A comparison between intravenous lidocaine and ketamine on acute and chronic pain after open nephrectomy: A prospective, double-blind, randomized, placebo-controlled study |
| Q43606194 | A pilot study of darbepoetin alfa for prophylactic neuroprotection in aortic surgery |
| Q56777696 | A prospective cohort study evaluating associations among delirium, postoperative cognitive dysfunction, and apolipoprotein E genotype following open aortic repair |
| Q36205215 | Administration of lidocaine to prevent cognitive deficit in patients undergoing coronary artery bypass grafting and valve plasty: a systematic review and meta-analysis. |
| Q35931250 | Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study |
| Q37598381 | Arterial hyperoxia during cardiopulmonary bypass and postoperative cognitive dysfunction |
| Q26781711 | Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base |
| Q43061147 | Avoiding stroke during cardiac surgery |
| Q37664861 | Benefits and risks of maintaining normothermia during cardiopulmonary bypass in adult cardiac surgery: a systematic review. |
| Q23909719 | Brain resuscitation in the drowning victim |
| Q36019259 | Cardiac surgery, the brain, and inflammation |
| Q38667391 | Cognitive Dysfunction, Delirium, and Stroke in Cardiac Surgery Patients |
| Q24186410 | Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery |
| Q57689177 | Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults |
| Q30546198 | Cortical β-amyloid levels and neurocognitive performance after cardiac surgery |
| Q34158087 | Decompression illness |
| Q34124787 | Developmental disability in the young and postoperative cognitive dysfunction in the elderly after anesthesia and surgery: do data justify changing clinical practice? |
| Q47404107 | Effect of intravenous lidocaine on the transcerebral inflammatory response during cardiac surgery: a randomized-controlled trial |
| Q90228060 | Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection |
| Q37476969 | Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery |
| Q37755882 | Is there a future for neuroprotective agents in cardiac surgery? |
| Q36329056 | Local Anaesthetic Infiltration and Indwelling Postoperative Wound Catheters for Patients with Hip Fracture Reduce Death Rates and Length of Stay |
| Q34056910 | Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review |
| Q38066970 | Medical management of acute pain in patients with chronic pain |
| Q52604751 | Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms. |
| Q87615885 | Neurological complications of cardiac surgery |
| Q48176970 | Neuroprotection after major cardiovascular surgery. |
| Q90150755 | Neuroprotection against stroke and encephalopathy after cardiac surgery |
| Q47148833 | Neuroprotective Anesthesia Regimen and Intensive Management for Pediatric Cardiac Surgery with Cardiopulmonary Bypass: a Review and Initial Experience |
| Q26749235 | Neuroprotective effect of lidocaine: is there clinical potential? |
| Q27003984 | Neuroprotective effects of intravenous anesthetics: a new critical perspective |
| Q35648133 | Neuroprotective effects of intravenous lidocaine on early postoperative cognitive dysfunction in elderly patients following spine surgery |
| Q35927406 | Obesity and post-operative cognitive dysfunction: a systematic review and meta-analysis |
| Q37601299 | Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery |
| Q37808136 | Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials |
| Q35464790 | Population pharmacokinetics of lidocaine administered during and after cardiac surgery |
| Q28086981 | Postoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly |
| Q36556891 | Predictors of cognitive recovery after cardiac surgery |
| Q37896693 | Pro con debate: the use of regional vs systemic analgesia for neonatal surgery. |
| Q58545353 | Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018 |
| Q26780541 | Risk Factors Associated with Cognitive Decline after Cardiac Surgery: A Systematic Review |
| Q38042547 | The dementia of cardiac disease |
| Q48211918 | Time course of acute neuroprotective effects of lidocaine evaluated by brain impedanciometry in the global ischemia model |
| Q45228851 | What to do when your brain turns blue? Considerations during aortic arch surgery |
| Q87585683 | [Update on the pharmacology and effects of local anesthetics] |
Search more.